Health News Archive - December 20, 2005
Breathing polluted air found in urban areas promotes heart disease, especially when accompanied by a fatty diet, researchers who tested the theory on mice said on Tuesday.
CHICAGO (Reuters) - More than one in three American adolescents are physically unfit and have many of the risk factors for heart disease, researchers said on Tuesday.
CHICAGO (Reuters) - Breathing polluted air found in urban areas promotes heart disease, especially when accompanied by a fatty diet, researchers who tested the theory on mice said on Tuesday.
CHICAGO (Reuters) - Men complaining of erection problems should be checked and monitored for heart trouble, researchers said on Tuesday. Erectile dysfunction can have a variety of origins including cardiovascular disease, and sufferers can easily obtain pharmacological relief from a physician.
Bee sting therapy is not effective in treating the symptoms of multiple sclerosis (MS), and does not improve quality of life, according to the first controlled study to investigate the alternative treatment in MS patients.
Individuals diagnosed with a first malignant melanoma of the skin have a significantly increased risk of being diagnosed with a second malignant melanoma, according to a report in the current issue of the International Journal of Cancer.
NEW YORK (Reuters Health) - A population-based, prospective study of elderly British individuals shows that risk of memory loss increases over time with increasing levels of total blood homocysteine and decreasing folate levels. Homocysteine is an amino acid in the blood.
By Ed Leefeldt NEW YORK (Reuters) - As the first of the 75 million baby boomers touch 60 in January, there's good news for the men: They are catching up to women in life expectancy.
By Megan Rauscher NEW YORK (Reuters Health) - Screening chest x-ray detects a substantial number of lung cancers at an early potentially curable stage, according to initial findings from the largest US study of the efficacy of screening for lung cancer in men and women.
By Susan Heavey WASHINGTON (Reuters) - The U.S. Food and Drug Administration approved a new drug to treat the most common type of kidney cancer on Tuesday, hailing it as a major advance in slowing tumor growth.